seeks to publish innovative papers concerned with all aspects of the brain-behavior relationship, including (but by no means limited to):
– neurobehavioral disturbances, including diagnosis and treatment, social and
legal consequences, ethical and moral problems, etc.
– the brain/mind problem;
– general or specific theories of brain function and development, cognitive and
emotional processes, speech and language functions, etc.
Authors are encouraged to submit manuscripts on theoretical and clinical topics in neuropsychology, broadly understood; interdisciplinary studies that explore issues not previously regarded as strictly neuropsychological are particularly welcome.
Acta Neuroopsychologica publishes articles of several types:
– experimental and clinical research papers (group studies, case studies, metaanalyses);
– theoretical essays;
– reviews (normally by invitation of the Editors, but unsolicited submissions of
particular value can be considered);
– letters to the editor (at the Editors' discretion, these can be published as commentary
– book reviews.
From time to time the Editors may also organize a Clinical Forum, which will feature an invited lead paper accompanied by 3-5 commentaries by independent researchers active in the same field, and the original author's response to the commentaries. Readers are cordially invited to submit requests, proposals, suggestions, and nominations for review and clinical forum articles.
Authors submitting papers are required to provide a 200-300 word abstract, preferably structured. This is especially important for the proper indexing and citation of papers. The structure of the abstract should generally reflect the structure of the article as a whole. Below the abstract the authors should give 3-6 key words, which as a general rule should not be terms that occur in the title of the paper. The purpose of key words is to direct the attention of search engines to an article, and these programs scan titles first for the search string, so the reappearance of words from the title among the key words is pointless and deprives the author of a valuable opportunity to attract reader interest.
The essential features of a structured abstract for a clinical or empirical research
study are given below.
Describe the background to the study, including the central problems or issues and their importance, the aims and objectives of the study, research questions or hypotheses advanced, etc.
Material and methods:
Outline the research subjects/participants with relevant demographics and clinical information, the basic tests and parameters, and the experimental design, including statistical methods if different from routine tests and measures.
Outline the important and relevant results generated by the experiment in general terms, without undue specificity of data.
The most important conclusions and implications of the study, with particular emphasis on any implications for clinical practice.
The foregoing should be treated as a model and not a prescription. Essays of a more discursive nature need not have a structured abstract. If the Editors upon review of the manuscript feel that the abstract should be structured, they will ask the author(s) to do so prior to publication.
For detailed regulations, see the Editorial Policy. All manuscripts should be sent to the Editor-in-Chief. Submissions should be sent in the form of an electronic mail message with attachments, sent to the Editor's address as indicated in the Editorial Policy, or on a 3.5", 2HD, IBM-formatted diskette (with printout) sent by post. No submitted materials will be returned to the authors; please do not send original illustrations until the article has been reviewed and accepted for publication. Hard-copy submissions not accompanied by a diskette or e-mail attachment cannot be accepted, since the manuscripts are sent to the referees only in electronic form. Please send text files in Rich Text Format (*.rtf), with scanned illustrations in JPEG (*.jpg) or bitmap (*.bmp) format; other formats should be explicitly cleared with the Editor before submission.
Manuscripts are accepted for publication subject to the following conditions:
– Copyright must be transferred by the author(s) to Agencja Wydawnicza MEDSPORTPRESS prior to publication; a form for this purpose will be sent at the same time as the galley proofs.
– The work as submitted must be the original work of the author(s), containing no plagiarism, and not previously published or submitted for consideration in another journal or publication.
– All the co-author(s), if any, are assumed to have read and accepted the manuscript prior to its submission and agreed to its publication in
and to the order in which they are listed. Unless otherwise expressly provided, the first author is responsible for making all editorial decisions on behalf of all the authors and obtaining their consent to emendations and final publication. Galley proofs will be sent only to the first author. The first author alone will be held responsible for meeting these conditions; neither the Editors nor the Publisher will be responsible for misunderstandings among the co-authors of a given article.
– The necessary permissions must be obtained in writing from the person(s) holding authorial rights to any text, illustration, or other material which is reproduced or derived from a copyrighted source beyond the scope of the "fair use" principle. No material should be reproduced from a published source without explicit citation.
– The work may not include content that is abusive, defamatory, libelous, obscene, fraudulent, or in violation of applicable laws, including international and national laws against the unauthorized disclosure of private and personal information.
If the manuscript is accepted for publication, the authors may use the substance of their work in future publications, provided that its prior publication in
is properly and explicitly acknowledged.
Ten complimentary offprints of the article and a complimentary copy of the issue in which the article appears will be sent to the first or sole author of articles. Larger quantities of offprints may be ordered at a special discount price by contacting the publisher directly:
The editors will accept only those works which are acknowledged by the
reviewers and the editors to be thematically appropriate works making an
original contribution to progress in science and/or clinical practice.
The signature of all authors
on the letter of submission signifies that:
Once the manuscript has been registered at the
Editorial Office, the first author is notified only by e-mail giving the
reference number for future correspondence. The registered manuscripts are sent
to two reviewers for scientific evaluation. The evaluation process should not
take longer than 3 months, but the editors cannot guarantee an editorial
decision within any established deadline.
• the submitted manuscript is the authors' own work;
• the research results have not been published or submitted for publication
• all the authors named on the title page have consented to the submission of
this work for publication in
Received manuscripts are first examined by the
editors. Manuscripts considered unsuitable for
immediately returned to the author without further review.
Manuscripts are accepted unconditionally if both reviewers agree that the work
can be published in its present form. If the reviewers disagree or feel that
the manuscript should be accepted subject to specific corrections, the editors
may decide to send the work to another reviewer or return it to the author for
The ultimate decision to accept for publication, accept subject to correction,
or reject a work is the prerogative of the editors and cannot be appealed. The
editors are not obliged to justify their decision.
Conflict of interests
The editors of
the authors of research articles are not financially involved in a company
whose product is presented in the text, or in a competing company.
The authors of a research
article should disclose at the time of submission any financial arrangement
they may have with a company whose product figures prominently in the submitted
manuscript. Such information will be held in confidence while the manuscript is
under review and will not influence the scientific evaluation of the work, but
if the article is accepted for publication, the editors will either agree with
the authors how such information is to be communicated to the reader, or decide
to forego such notification.
requires that reviewers, associate editors, editors, and senior editors reveal
in a letter to the Editor-in-Chief any relationships they may have that could
be construed as causing a conflict of interest with regard to the author of a
manuscript under review. The letter should include a statement of any financial
relationships with commercial companies involved with a medical product under
Ghostwriting and guest
Manuscripts submitted for publication will not be sent to a reviewer from the
same home institution as the author(s).
Ghostwriting and guest authorship
are examples of scientific misconduct. Any identified cases will be disclosed, including notification of appropriate
bodies or institutions (authors' home institutions, scientific societies, associations of
academic editors, etc.).
Materials taken from other sources must be accompanied by a written statement
from the first author and the publisher of the original publication giving
permission for reproduction in
Permission should be obtained in writing from the first author of papers still
in press, and from the source of any unpublished data or personal
communications used in the article.
Changing the biographical details of a patient in order to protect his/her
identity is a form of data alteration and should be avoided. However, the
authors of clinical papers are obliged to protect the patient's privacy rights.
Only clinically or scientifically important information should be published.
Therefore, if it is possible to identify a patient from the information given
in the article, the authors must obtain the written consent of the patient or
his/her guardian to publish his/her data, including photographs, radiological
images, etc., prior to submission. Details regarding the race, ethnicity,
cultural background or religion of any person involved in the study should be
disclosed only when in the author's considered opinion such details have a
bearing on the course of the disease and/or treatment under discussion in the
Upon acceptance of a manuscript for publication, the authors transfer copyright
to the MEDSPORTPRESS Publishing House. Once an article is accepted for
information it contains cannot be revealed in the public media until the
publication date of the issue in which the article appears.
Upon acceptance all published manuscripts become the permanent property of
MEDSPORTPRESS, the Publisher of
and may not
be published elsewhere without written permission from MEDSPORTPRESS.
Every effort is made by the Publisher and Editorial Board to see that no
inaccurate or misleading data, opinions or statements appear in
. Nevertheless, the
substantive contents of articles and advertisements remain the sole
responsibility of the author, sponsor, or advertiser concerned. Accordingly,
neither the Publisher nor the Editorial Board accept any liability whatsoever
for the consequences of any such inaccurate or misleading data, opinion, or
Every effort is made to ensure that drug doses and
other quantities are presented accurately. Nevertheless, the editors advise all
readers to apply methods and techniques involving drug usage and other
treatment procedures described in
compliance with the recommendations and instructions of the drug or equipment
manufacturer as published in the reader's own country.